Alpine Global Management, LLC Reata Pharmaceuticals Inc Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 16, 2018
SELL
$20.0 - $30.19 $250,000 - $377,375
-12,500 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$22.39 - $33.27 $33,585 - $49,905
1,500 Added 13.64%
12,500 $354,000
Q3 2017

Nov 14, 2017
BUY
$26.29 - $31.88 $289,190 - $350,680
11,000
11,000 $342,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email